SOURCE: Key Capital Corporation

October 25, 2006 10:17 ET

Key Capital Advises of Pharmaceutical Interests

SANTA CLARA, CA -- (MARKET WIRE) -- October 25, 2006 -- Key Capital Corporation (PINKSHEETS: KCPC) advises that the Company has taken conditional interests in two pharmaceutical companies, Comox Pharma Limited of Melbourne, Australia and Healthstar Medical Development Company of Beijing, China.

Key Capital is in process of facilitating a $10 million capital raising and public listing for Comox Pharma and a raising of $15 million and public listing for Healthstar.

Comox Pharma has patents for products that will prove to be of substantial health benefit, including a new combination statin drug that will eliminate the major side effects associated with the use of cholesterol lowering statins which are the world's largest prescription drug class with a market in excess of $25 billion.

Healthstar, with a number of unique products and current revenues of approximately $30 million, has conditionally joint ventured the Comox Pharma products for the China market.

Key Capital's business is focused on transactional investment banking, financing and business and strategic advice.

Safe Harbor Statement

The information in this release, other than historical information, may be considered forward-looking statements within the provisions of the Private Securities Litigation Reform Act of 1995. Projection and other forward-looking statements and management expectations regarding future events and/or financial performance of the Company -- although given in good faith -- are inherently uncertain and actual events and/or results may differ materially.

Contact Information